Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1/2 1

Status

Not yet recruiting 1Completed 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 927Neoplasms 609Breast Neoplasms 605Colorectal Neoplasms 458Neoplasm Metastasis 394Ovarian Neoplasms 328Melanoma 313Prostatic Neoplasms 311Lung Neoplasms 294Multiple Myeloma 292Recurrence 278Squamous Cell Carcinoma of Head and Neck 246Stomach Neoplasms 229Pancreatic Neoplasms 229Leukemia, Myeloid, Acute 220Triple Negative Breast Neoplasms 191Endometrial Neoplasms 190Carcinoma, Renal Cell 182Lymphoma, Non-Hodgkin 179Carcinoma, Hepatocellular 177Small Cell Lung Carcinoma 165Leukemia, Lymphocytic, Chronic, B-Cell 156Advanced Solid Tumors 156Lymphoma, Follicular 148Urinary Bladder Neoplasms 139Lymphoma, Large B-Cell, Diffuse 138Lymphoma 137Advanced Solid Tumor 137Uterine Cervical Neoplasms 134Head and Neck Neoplasms 134

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × Cancer Cachexia × 1 year × Clear all
NCT07584057 2026-05-13

An Phase I/IIa Clinical Study to Evaluate the Safety/Tolerability, Pharmacokinetics and Preliminary Efficacy of INB301 Injection in Patients With Cancer Cachexia

Yunnan Baiyao Group Co., Ltd.

Phase 1/2 Not yet recruiting
146 enrolled

Cancer Cachexia

NCT06476197 2025-07-17

Exploratory Trial of SAT-003 in Cancer Cachexia Patients With Discontinued Chemotherapy

S-Alpha Therapeutics, Inc.

Phase NA Completed
15 enrolled

Cancer Cachexia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡